The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Leif Thuesen
Showing 1-20 of 41 articles
Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy
Ladwiniec A,
Walsh S,
Holm N,
Hanratty C,
Mäkikallio T,
Kellerth T,
Hildick-Smith D,
Mogensen L,
Hartikainen J,
Menown I,
Erglis A,
Eriksen E,
Spence M,
Thuesen L,
Christiansen E
June 25, 2020 | 10.4244/EIJ-D-19-01003
Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study
Pareek M,
Madsen M,
Warnakula Olesen K,
Jensen L,
Christiansen E,
Kristensen SD,
Lassen JF,
Thuesen L,
Bøtker H,
Maeng M
December 6, 2019 | 10.4244/EIJ-D-19-00503
Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments
Kjoller-Hansen L,
Bligaard N,
Kelbæk H,
Christiansen E,
Thuesen L,
Hansen PR,
Engstrøm T,
Junker A,
Abildgaard U,
Lassen JF,
Jensen JS,
Jeppesen JL,
Galloe A
September 20, 2018 | 10.4244/EIJ-D-18-00396
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial
Bourantas C,
Farooq V,
Zhang Y-J,
Muramatsu T,
Gogas B,
Thuesen L,
McClean D,
Chevalier B,
Windecker S,
Koolen J,
Ormiston J,
Whitbourn R,
Dorange C,
Rapoza R,
Onuma Y,
Garcia-Garcia H,
Serruys P
March 20, 2015 | 10.4244/EIJY14M04_11
Feasibility and early safety of hybrid coronary revascularisation combining off-pump coronary surgery through J-hemisternotomy with percutaneous coronary intervention
Modrau I,
Nielsen P,
Bøtker H,
Christiansen E,
Krusell L,
Kaltoft A,
Terkelsen CJ,
Kristensen SD,
Lassen JF,
Thuesen L,
Maeng M
February 20, 2015 | 10.4244/EIJV10I10A195
Randomised comparison of manual compression and FemoSeal™ vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) study
Holm N,
Sindberg B,
Schou M,
Maeng M,
Kaltoft A,
Bottcher M,
Krusell L,
Hjort J,
Thuesen L,
Terkelsen CJ,
Christiansen E,
Bøtker H,
Kristensen SD,
Lassen JF
June 20, 2014 | 10.4244/EIJV10I2A31
Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial
Antonsen L,
Thayssen P,
Hansen H,
Maeng M,
Tilsted H,
Bøtker H,
Ravkilde J,
Madsen M,
Sørensen H,
Thuesen L,
Lassen JF,
Jensen L
June 20, 2014 | 10.4244/EIJV10I2A35
Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
Serruys P,
Onuma Y,
Garcia-Garcia H,
Muramatsu T,
van Geuns R,
De Bruyne B,
Dudek D,
Thuesen L,
Smits PC,
Chevalier B,
McClean D,
Koolen J,
Windecker S,
Whitbourn R,
Meredith I,
Dorange C,
Veldhof S,
Hebert K,
Rapoza R,
Ormiston J
March 20, 2014 | 10.4244/EIJV9I11A217
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials
Gogas B,
Bourantas C,
Garcia-Garcia H,
Onuma Y,
Muramatsu T,
Farooq V,
Diletti R,
van Geuns R,
De Bruyne B,
Chevalier B,
Thuesen L,
Smits PC,
Dudek D,
Koolen J,
Windecker S,
Whitbourn R,
McClean D,
Dorange C,
Miquel-Hebert K,
Veldhof S,
Rapoza R,
Ormiston J,
Serruys P
October 25, 2013 | 10.4244/EIJV9I6A115
Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions
Abizaid A,
Ormiston J,
Fajadet J,
Mauri L,
Schofer J,
Verheye S,
Dens J,
Thuesen L,
Macours N,
Qureshi A,
Spaulding C
October 25, 2013 | 10.4244/EIJV9I6A116
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Weissman N,
Barragan P,
Scott D,
Valdés Chávarri M,
West N,
Kelbæk H,
Whitbourn R,
Walters D,
Kubica J,
Thuesen L,
Masotti M,
Banning A,
Sjogren I,
Stables R,
Allocco DJ,
Dawkins K
July 26, 2013 | 10.4244/EIJV9I3A52
Sex- and age-related differences in clinical outcome after primary percutaneous coronary intervention
Jakobsen L,
Niemann T,
Thorsgaard N,
Nielsen T,
Thuesen L,
Lassen JF,
Jensen L,
Thayssen P,
Ravkilde J,
Tilsted H,
Mehnert F,
Johnsen SP
December 28, 2012 | 10.4244/EIJV8I8A139
The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation
Thayssen P,
Jensen L,
Lassen JF,
Tilsted H,
Kaltoft A,
Christiansen E,
Hansen K,
Ravkilde J,
Maeng M,
Krusell L,
Madsen M,
Sørensen H,
Thuesen L
September 28, 2012 | 10.4244/EIJV8I5A91
Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease
Jensen L,
Thayssen P,
Farkas D,
Hougaard M,
Terkelsen CJ,
Tilsted H,
Maeng M,
Junker A,
Lassen JF,
Horv E,
Sørensen H,
Thuesen L
August 24, 2012 | 10.4244/EIJV8I4A72
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial
Brugaletta S,
Gomez-Lara J,
Bruining N,
Radu M,
van Geuns R,
Thuesen L,
McClean D,
Koolen J,
Windecker S,
Whitbourn R,
Oberhauser J,
Rapoza R,
Ormiston J,
Garcia-Garcia H,
Serruys P
July 27, 2012 | 10.4244/EIJV8I3A54
A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial
Nielsen H,
Klaaborg K,
Nissen H,
Terp K,
Mortensen P,
Kjeldsen B,
Jakobsen C-J,
Andersen H,
Egeblad H,
Krusell L,
Thuesen L,
Hjortdal V
July 27, 2012 | 10.4244/EIJV8I3A58
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study
Gomez-Lara J,
Diletti R,
Brugaletta S,
Onuma Y,
Farooq V,
Thuesen L,
McClean D,
Koolen J,
Ormiston J,
Windecker S,
Whitbourn R,
Dudek D,
Dorange C,
Veldhof S,
Rapoza R,
Regar E,
Garcia-Garcia H,
Serruys P
June 27, 2012
Side branch fractional flow reserve measurements after main vessel stenting: a Nordic-Baltic Bifurcation Study III substudy
Kumsars I,
Narbute I,
Thuesen L,
Niemelä M,
Steigen T,
Kervinen K,
Sondore D,
Holm N,
Lassen JF,
Christiansen E,
Maeng M,
Jegere S,
Juhnevica D,
Erglis A
February 21, 2012 | 10.4244/EIJV7I10A186
Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial
Dudek D,
Onuma Y,
Ormiston J,
Thuesen L,
Miquel-Hebert K,
Serruys P
January 20, 2012 | 10.4244/EIJV7I9A168
In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry
Galassi A,
Tomasello S,
Reifart N,
Werner G,
Sianos G,
Bonnier H,
Sievert H,
Ehladad S,
Bufe A,
Schofer J,
Gershlick A,
Hildick-Smith D,
Escaned J,
Erglis A,
Sheiban I,
Thuesen L,
Serra A,
Christiansen E,
Buettner A,
Costanzo L,
Barrano G,
Di Mario C
August 30, 2011 | 10.4244/EIJV7I4A77
1
2
3
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023